157 related articles for article (PubMed ID: 22504097)
1. Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
Tan AC; Eriksson EM; Kedzierska K; Deliyannis G; Valkenburg SA; Zeng W; Jackson DC
Antiviral Res; 2012 May; 94(2):168-78. PubMed ID: 22504097
[TBL] [Abstract][Full Text] [Related]
2. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
4. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
[TBL] [Abstract][Full Text] [Related]
5. A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins.
Engler OB; Schwendener RA; Dai WJ; Wölk B; Pichler W; Moradpour D; Brunner T; Cerny A
Vaccine; 2004 Nov; 23(1):58-68. PubMed ID: 15519708
[TBL] [Abstract][Full Text] [Related]
6. Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice.
Tan AC; La Gruta NL; Zeng W; Jackson DC
J Immunol; 2011 Aug; 187(4):1895-902. PubMed ID: 21765016
[TBL] [Abstract][Full Text] [Related]
7. An accelerated vaccine schedule with a poly-antigenic hepatitis C virus MVA-based candidate vaccine induces potent, long lasting and in vivo cross-reactive T cell responses.
Fournillier A; Gerossier E; Evlashev A; Schmitt D; Simon B; Chatel L; Martin P; Silvestre N; Balloul JM; Barry R; Inchauspé G
Vaccine; 2007 Oct; 25(42):7339-53. PubMed ID: 17875349
[TBL] [Abstract][Full Text] [Related]
8. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
9. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
[TBL] [Abstract][Full Text] [Related]
10. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptides.
Langhans B; Schweitzer S; Braunschweiger I; Schulz M; Sauerbruch T; Spengler U
Cytometry A; 2005 May; 65(1):59-68. PubMed ID: 15800857
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus mutation affects proteasomal epitope processing.
Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.
Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ
Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of an influenza virus-vectored vaccine carrying the hepatitis C virus protein epitopes in mice.
Zhang S; Sun F; Ren T; Duan Y; Gu H; Lai C; Wang Z; Zhang P; Wang X; Yang P
Antiviral Res; 2017 Sep; 145():168-174. PubMed ID: 28778831
[TBL] [Abstract][Full Text] [Related]
17. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
[TBL] [Abstract][Full Text] [Related]
18. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.
Neumann-Haefelin C; McKiernan S; Ward S; Viazov S; Spangenberg HC; Killinger T; Baumert TF; Nazarova N; Sheridan I; Pybus O; von Weizsäcker F; Roggendorf M; Kelleher D; Klenerman P; Blum HE; Thimme R
Hepatology; 2006 Mar; 43(3):563-72. PubMed ID: 16496339
[TBL] [Abstract][Full Text] [Related]
19. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity.
Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS
J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709
[TBL] [Abstract][Full Text] [Related]
20. Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.
Chua BY; Pejoski D; Turner SJ; Zeng W; Jackson DC
J Immunol; 2011 Aug; 187(4):1692-701. PubMed ID: 21742967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]